Gritstone Oncology Company Profile

21:35 EDT 21st September 2019 | BioPortfolio

Gritstone Oncology is a privately-held, next-generation personalized cancer immunotherapy company. Gritstone brings together distinguished scientific founders, an experienced and diverse management team, a seasoned and successful board of directors, and deep financial backing to tackle fundamental challenges at the intersection of cancer genomics, immunology, and immunotherapy design. The company’s initial goal is to identify and deploy therapeutic neoantigens from individual patients’ tumor to develop novel treatments for lung cancer. Gritstone Oncology is headquartered in the San Francisco Bay Area with certain key functions located in Cambridge, MA. The company launched in October 2015 with a Series A financing of $102 million from leading blue-chip biotechnology investors, including Versant Ventures, The Column Group, and Clarus Ventures. More information can be found at

News Articles [534 Associated News Articles listed on BioPortfolio]

Public offering nets $70.3mm for Gritstone Oncology

Gritstone Oncology Inc. (developing tumor-specific immunotherapies) netted $70.3mm through the public sale of 6.5mm common shares at $11.50. Proceeds will support Phase I/II studies with neoantigen-ba...

Gritstone begins treatment in GRANITE-001’s Phase I/II trial

Gritstone Oncology has commenced dosing of patients in a Phase I/II clinical trial evaluating its personalised immunotherapy candidate GRANITE-001 in...Read More... The post Gritstone begins treatment...

Gritstone to speed up early-stage study for solid tumor drug

After FDA feedback, Gritstone Oncology's early-stage SLATE study is expected to be accelerated by up to six months by using p -More- 

Follow-on funding pulls in nearly $75M for Gritstone

A follow-on funding has brought in $74.8 million for Gritstone Oncology.  -More- 

Gritstone Oncology to Host Event with Oncology Key Opinion Leaders Discussing Neoantigen-based Immunotherapy During ASCO Annual Meeting

EMERYVILLE, Calif., May 30, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight mult...

Gritstone Oncology to Present at Needham Healthcare Conference

EMERYVILLE, Calif., April 03, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight mu...

Gritstone Oncology (GRTS) Presents At Biotechnology Conference - Slideshow

Gritstone Oncology to Present at Two Upcoming Investor Conferences in June

EMERYVILLE, Calif., June 05, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight mul...

Drugs and Medications [9 Associated Drugs and Medications listed on BioPortfolio]

Neutrexin (trimetrexate glucuronate for injection) [medimmune oncology, inc.]

NEUTREXIN (trimetrexate glucuronate for injection)

Rubraca [clovis oncology, inc.]

These highlights do not include all the information needed to use RUBRACA safely and effectively. See full prescribing information for RUBRACA.RUBRACA (rucaparib) tablets, for oral useInitial U.S. App...

Carboplatin [sagent pharmaceuticals]

Carboplatin Injection(carboplatin aqueous solution)

Carboplatin [meitheal pharmaceuticals inc.]

Carboplatin Injection(carboplatin aqueous solution)

Carboplatin [hospira, inc.]

Carboplatin Injection

PubMed Articles [1384 Associated PubMed Articles listed on BioPortfolio]

Communication training in oncology needs a theoretical framework.

Radiation Oncology Quality Assessment Tool: A proposal for a new audit tool in modern radiation oncology.

As a consequence of the development of improved treatment techniques and utilisation of digital records in radiation oncology, the RANZCR Peer Review Audit Tool has become outdated. The aim of this in...

Perspectives on Geriatric Oncology Research presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting.

Immunotherapy and the Interventional Oncologist: Challenges and Opportunities-A Society of Interventional Oncology White Paper.

Interventional oncology is a subspecialty field of interventional radiology that addresses the diagnosis and treatment of cancer and cancer-related problems by using targeted minimally invasive proced...

Cardio-Oncology Fellowship Training and Education.

With the rapid development of novel cancer therapeutics and the growing number of cancer survivors, there is significant demand for cardio-oncology experts to care for these patients. As such, it has ...

Clinical Trials [683 Associated Clinical Trials listed on BioPortfolio]

Examining Patient Preferences About the IBM Watson Oncology Clinical Decision Support System

The purpose of this study is to learn what cancer patients think about IBM Watson Oncology. IBM Watson Oncology is a computer program designed to help inform oncologists about the best che...

Support of the Sexual Health in Oncology

Implementation of sexual health support program in oncology department. This program is organized in 3 axes. One is to inform the side effects of treatment on sexual health. There is a co...

Clinical Concordance Study Between Watson for Oncology and Clinician Practice

At present, Watson for Oncology has been applied in 14 countries worldwide, including China, the United States, Holland, Thailand, India, Korea, Poland, Slovakia and Bangladesh. In a doubl...

Osteopathic Manipulative Treatment in Oncology Patients' Management

The aim of present study was to study the osteopathic manipulative effects on pain relief and quality of life improvement on hospitalized oncology geriatric patients. A non-randomized comp...

Hospital Based Registry of Childhood Cancer in Pediatric Oncology Units in French Speaking Africa

The ultimate aim of this registry is to collect precise information concerning the children coming to oncology units working with the French African Oncology Group. This data will help to ...

Companies [792 Associated Companies listed on BioPortfolio]

Gritstone Oncology

Gritstone Oncology is a privately-held, next-generation personalized cancer immunotherapy company. Gritstone brings together distinguished scientific founders, an experienced and ...

Gritstone Oncology, Inc.

Gritstone is a privately-held company developing personalized cancer immunotherapies to fight multiple cancer types. Gritstone brings together distinguished scientific founders, a...

Takeda Oncology

Takeda Oncology, headquartered in Cambridge, MA, delivers novel medicines to patients with cancer worldwide through its commitment to science, breakthrough innovation and passion ...


OncLive is the official website for Intellisphere’s Oncology Specialty Group, which publishes Oncology & Biotech News, OncologyLive, Oncology Nursing News, and Contemporary O...

Cold Spring Publishing, LLC

Cold Spring Publishing, LLC, (CSP) is a medical publishing company whose principals have more than 50 years of combined publishing experience, with a specific focus in oncology. CSP publishes JNCCN --...

More Information about "Gritstone Oncology" on BioPortfolio

We have published hundreds of Gritstone Oncology news stories on BioPortfolio along with dozens of Gritstone Oncology Clinical Trials and PubMed Articles about Gritstone Oncology for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Gritstone Oncology Companies in our database. You can also find out about relevant Gritstone Oncology Drugs and Medications on this site too.

Quick Search

Relevant Topics

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Corporate Database Quicklinks

Searches Linking to this Company Record